VURAGADGENE PARVEC
UNII UTU9XL4BCZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Vuragadgene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UTU9XL4BCZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3056068-67-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

UTU9XL4BCZ

CAS Registry Number

3056068-67-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VURAGADGENE PARVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C223318

National Cancer Institute reference terminology for clinical and research data.

INN ID

13960

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-93

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vuragadgene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VURAGADGENE PARVEC

Common Names & Synonyms

DNA (RECOMBINANT ADENO-ASSOCIATED VIRUS 2 VECTOR AAV2-GAD67 CYTOMEGALOVIRUS EARLY ENHANCER FUSION WITH CHICKEN .BETA.-ACTIN GENE PROMOTER PLUS HUMAN GLUTAMATE DECARBOXYLASE ISOENZYME GAD67 GENE PLUS WOODCHUCK HEPATITIS VIRUS POST-TRANSCRIPTIONAL REGULATORY ELEMENT WPRE PLUS BOVINE GROWTH HORMONE GENE POLYADENYLATION SIGNAL PLUS ADENO ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT FLANKS-SPECIFYING)

VURAGADGENE PARVEC [INN]

VURAGADGENE PARVEC [USAN]